Merck KGaA (OTCMKTS:MKGAF – Get Free Report)’s stock price dropped 7% on Wednesday . The company traded as low as $138.6690 and last traded at $138.6690. Approximately 116 shares traded hands during mid-day trading, a decline of 87% from the average daily volume of 864 shares. The stock had previously closed at $149.11.
Merck KGaA Stock Performance
The firm has a market cap of $17.92 billion, a PE ratio of 21.17 and a beta of 0.96. The company has a 50 day simple moving average of $135.54 and a 200-day simple moving average of $132.43. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.
About Merck KGaA
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Read More
- Five stocks we like better than Merck KGaA
- What Makes a Stock a Good Dividend Stock?
- Intel Snaps Up AI Tech for Pennies on the Dollar
- There Are Different Types of Stock To Invest In
- 4 Quantum Stocks to Watch as the Next Computing Revolution Unfolds
- Investing in Commodities: What Are They? How to Invest in Them
- Massive Breakout in Industrials: 3 Must-Watch Stocks Now
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
